Investors

Date	Name	Title	Type	Shares Traded	Price Range
May 6, 2013	van plew daniel p	Officer	Disposition (Non Open Market)	15,323	260.44
Sep 16, 2008	roberts william	Officer	Disposition (Non Open Market)	15,308	21.16
Apr 27, 2009	roberts william	Officer	Automatic Sell	15,160	12.74
Apr 27, 2009	roberts william	Officer	Option Execute	15,160	6.50
Aug 1, 2011	powchik peter	Officer	Option Execute	15,144	15.64
Nov 8, 2012	powchik peter	Officer	Sell	15,144	138.59 - 139.05
Aug 23, 2012	mccorkle douglas s	Officer	Option Execute	15,125	21.25 - 30.63
Nov 26, 2012	baker charles a	Director	Automatic Sell	15,000	171.45 - 175.14
Nov 26, 2012	baker charles a	Director	Option Execute	15,000	9.17
Mar 21, 2013	brown michael s	Director	Automatic Sell	15,000	172.61 - 174.13
Mar 21, 2013	brown michael s	Director	Option Execute	15,000	18.61
May 15, 2013	brown michael s	Director	Option Execute	15,000	24.41
Aug 7, 2012	gilman alfred g	Director	Sell	15,000	139.56
Aug 7, 2012	gilman alfred g	Director	Option Execute	15,000	15.80
Aug 15, 2011	goldberg murray a	Officer	Option Execute	15,000	11.64
Feb 14, 2012	goldstein joseph l	Director	Automatic Sell	15,000	110.02
Feb 14, 2012	goldstein joseph l	Director	Option Execute	15,000	24.41 - 33.42
Mar 9, 2011	goldstein joseph l	Director	Option Execute	15,000	9.17
Jul 25, 2012	powchik peter	Officer	Option Execute	15,000	16.80
Sep 18, 2012	powchik peter	Officer	Option Execute	15,000	16.80
Showing 201-220 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.